Pfizer Says Additional Analysis Shows Its Vaccine Is 95% Effective In Preventing COVID-19, Seeking FDA Authorization


This picture taken on May 23, 2020 shows a laboratory technician holding a dose of a COVID-19 novel coronavirus vaccine candidate ready for trial on monkeys at the National Primate Research Center of Thailand at Chulalongkorn University in Saraburi. (Photo by MLADEN ANTONOV/AFP via Getty Images)

OAN Newsroom
UPDATED 7:05 PM PT – Wednesday, November 18, 2020

Pfizer officials have stated additional analysis from its experimental coronavirus vaccine suggested it’s more than 95 percent effective in preventing COVID-19.

On Wednesday, Pfizer and BioNTech released the updated data after initially estimating last week their vaccine was more than 90 percent effective.

The drugmakers stated its effectiveness was consistent across all ages, races and ethnicities with no serious side effects. Additionally, BioNTech’s CEO plans to submit an emergency use authorization to the FDA within days.



Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN

GARDEN OF EDEN FOUND IN AFRICA

THE HISTORY AND ORIGIN OF THE ZULU PEOPLE

FIVE WAYS A WIFE CAN REST HER HUSBAND ON HER

BRIEF HISTORY OF NKALAHA.

MYSTERY OF IGBO COSMOLOGY

THE ORIGIN AND HISTORY OF UDI by Onyeji Nnaji

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji

ETHIOPIA:THE OLDEST PEOPLE IN THE MIDDLE EAST